Keros Therapeutics, Inc. ($KROS)
BIENAIME JEAN JACQUES โ Director
Shares
1,000
Price
$10.58
Total Value
$10,580.00
P&L
+4.3% (+$450.00)
Nearby Earnings
May 4, 2026
Transaction Details
| Insider | BIENAIME JEAN JACQUES |
|---|---|
| Title | Director |
| Transaction Date | May 15, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 19, 2026 |
| Shares Purchased | 1,000 |
| Price per Share | $10.58 |
| Total Value | $10,580.00 |
| Shares Owned After | 9,450 |
| Derivative | No |
| Accession Number | 0001221590-26-000009 |
| Document | View SEC Filing |